| Drug Name | Alectinib |
|---|---|
| Other Drug Names | AF-802; Alecensa; ALECENSARO; Alectinib hydrochloride; CH-5424802; RG-7853; RO-5424802; RO-5452802 |
| Chemical Name | 9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile |
| Formula | C30H34N4O2 |
| Mol. Wt. | 482.63 |
| CAS No. | 1256580-46-7 |
| UNII | LIJ4CT1Z3Y |
| Target-based Actions | ALK tyrosine kinase receptor family inhibitor; Anaplastic lymphoma kinase receptor inhibitor; RET tyrosine kinase receptor family inhibitor |
| ATC Codes | L01XE36 |
| Highest Status | 批准上市 |
| Originator Company | Chugai/Roche |
| Structure |
 |
Extended Information